Media Mentions

Read articles and view other media that members of the Parasites Without Borders team have contributed to.

Time for Texas to treat COVID-19 outbreaks like stormy weather

By ecropolis | febrero 4, 2022
Lee mas

How a Texas team created the first ‘open source’ COVID-19 shot

By ecropolis | febrero 3, 2022
Lee mas

What does it mean to be full vacinated?

By ecropolis | febrero 3, 2022
Lee mas

Houston vaccine researchers Dr. Peter Hotez and Dr. Maria Elena Bottazzi nominated by Rep. Fletcher for Nobel Peace Prize

By ecropolis | febrero 2, 2022
Lee mas

Dr. Peter Hotez and Opal Lee are among the Texans nominated for the 2022 Nobel Peace Prize

By ecropolis | febrero 2, 2022
Lee mas

A patent-free vaccine for the world

By ecropolis | febrero 1, 2022
Lee mas

Peter Hotez, MD, PhD, on his new COVID vaccine

By ecropolis | enero 31, 2022
Lee mas

AMA honors Houston physician with Scientific Achievement Award

By ecropolis | enero 31, 2022
Lee mas

Omicron continues to decline in Houston after explosive surge, new data show

By ecropolis | enero 31, 2022
Lee mas

How a new patent-free Covid-19 vaccine could help end the pandemic

By ecropolis | enero 30, 2022
Lee mas

Peter Hotez: Omicron isn’t the end of the pandemic; another Texas wave may come this summer

By ecropolis | enero 28, 2022
Lee mas

Connecticut native helps develop affordable COVID vaccine

By ecropolis | enero 28, 2022
Lee mas

Rest-of-Year COVID Forecast From Top Vaccine Scientist (and Connecticut Native)

By ecropolis | enero 27, 2022
Lee mas

Who will defend embattled scientists?

By ecropolis | enero 27, 2022
Lee mas

Vaccine Researcher Discusses Future of COVID-19

By ecropolis | enero 27, 2022
Lee mas

A new sub-variant of omicron, BA.2, has been detected in Connecticut. Here’s what we know about it.

By ecropolis | enero 27, 2022
Lee mas

Peter Hotez on the Texas-made COVID vaccine that could help billions

By ecropolis | enero 27, 2022
Lee mas

CORBEVAX, a new patent-free COVID-19 vaccine, could be a pandemic game changer globally

By ecropolis | enero 21, 2022
Lee mas

Vaccines of the future: The secret to getting us out of this pandemic?

By ecropolis | enero 20, 2022
Lee mas

Are you looking to get an N95 mask? Here’s how you can spot the counterfeit ones.

By ecropolis | enero 20, 2022
Lee mas

HEALY: Recognize Vaccine Efficacy, Rethink COVID Protocols

By ecropolis | enero 20, 2022
Lee mas

COVID-19 could go from pandemic to endemic, depending on vaccine rates

By ecropolis | enero 19, 2022
Lee mas

The New Normal: Where are we now in the Omicron surge?

By ecropolis | enero 18, 2022
Lee mas

What Will it Take to Vaccinate the World?

By ecropolis | enero 17, 2022
Lee mas

Editorial: Clowns like Sen. Rand Paul should stop trolling the adults determined to get us through the pandemic.

By ecropolis | enero 16, 2022
Lee mas

Texas scientists’ new Covid-19 vaccine is cheaper, easier to make and patent free

By ecropolis | enero 15, 2022
Lee mas

Infectious diseases: Vaccines the most mentioned term on Twitter Q4 2021

By ecropolis | enero 13, 2022
Lee mas

Coronavirus FAQ: Why are some folks hacking home COVID tests by swabbing their throat?

By ecropolis | enero 13, 2022
Lee mas

As COVID-19 surges, there are no hospital beds for others in need of care

By ecropolis | enero 13, 2022
Lee mas

ADL Southwest presents Popkin Award to Dr. Peter Hotez

By ecropolis | enero 13, 2022
Lee mas

Open-Source Vaccines Got More Funding From Tito’s Vodka Than the Government

By ecropolis | enero 11, 2022
Lee mas

New Corbevax vaccine could be global game changer

By ecropolis | enero 8, 2022
Lee mas

Dr. Peter Hotez: New Vaccine Gives Developing Nations a Chance . . . Key to Stopping Variants

By ecropolis | enero 7, 2022
Lee mas

From Texas to India, a patent-free Covid vaccine looks to bridge equity gaps

By ecropolis | enero 7, 2022
Lee mas

Omicron: ‘There is some very, very good news,’ Northwell Health CEO says

By ecropolis | enero 7, 2022
Lee mas

Reflections on the January 6th Insurrection

By ecropolis | enero 6, 2022
Lee mas

The New Normal: When could we finally see a peak in the COVID-19 climb?

By ecropolis | enero 5, 2022
Lee mas

A Texas team comes up with a COVID vaccine that could be a global game changer

By ecropolis | enero 5, 2022
Lee mas

New COVID-19 variants will emerge ‘unless we redouble’ global vaccination efforts, doctor says

By ecropolis | enero 4, 2022
Lee mas

This new, low-cost COVID-19 vaccine could be a game changer for low-income countries

By ecropolis | enero 4, 2022
Lee mas

Here’s What Houston Was Up To Last Week, January 3

By ecropolis | enero 4, 2022
Lee mas

US Sets Global Record of 1 Million New Reported Daily COVID Cases

By ecropolis | enero 4, 2022
Lee mas

Why this Covid-19 surge is ‘unprecedented in this pandemic’

By ecropolis | enero 3, 2022
Lee mas

New “no strings attached” TX-based COVID vaccine looks to combat global spread

By ecropolis | enero 1, 2022
Lee mas

US: Corbevax to be helpful in vaccinating India, neighbouring countries, says Texas Dr. Peter Hotez

By ecropolis | diciembre 31, 2021
Lee mas

Editorial: Houston-made Corbevax vaccine welcome news in pandemic fight

By ecropolis | diciembre 31, 2021
Lee mas

A new coronavirus vaccine heading to India was developed by a small team in Texas. It expects nothing in return.

By ecropolis | diciembre 30, 2021
Lee mas

Feeling déjà vu? 2022 set to begin in familiar fashion – with COVID-19 surging

By ecropolis | diciembre 30, 2021
Lee mas

Omicron makes people sick faster. Here’s what else you need to know for New Year’s weekend

By ecropolis | diciembre 29, 2021
Lee mas

COVID-19: ‘Omicron’s A Different Animal,’ Says Expert, Sounding Alarm Over In-Person Learning

By ecropolis | diciembre 29, 2021
Lee mas

[ctct form="259547" show_title="false"]

Parasites Without Borders

Un recurso educativo integral sobre todos los aspectos de las enfermedades parasitarias y su impacto en la humanidad en todo el mundo.

Donate to Parasites Without Borders Today!

Ayude a llevar la información médica y biológica más reciente sobre enfermedades causadas por parásitos eucariotas a todos los médicos y estudiantes de medicina en los Estados Unidos.

Scroll al inicio